|
|
Volumn 34, Issue 1, 2016, Pages 5-6
|
|
CETP inhibitors boost 'good' cholesterol to no avail
a
a
NONE
(Ireland)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENYLATE CYCLASE;
ANACETRAPIB;
ATEZOLIZUMAB;
CHOLESTEROL ESTER TRANSFER PROTEIN;
CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR;
DALCETRAPIB;
EVACETRAPIB;
HIGH DENSITY LIPOPROTEIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
TA 8995;
TORCETRAPIB;
UNCLASSIFIED DRUG;
AGE RELATED MACULAR DEGENERATION;
CANCER IMMUNOTHERAPY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
DRUG EFFECT;
DRUG SAFETY;
HEART INFARCTION;
HUMAN;
ISCHEMIC HEART DISEASE;
NONHUMAN;
NOTE;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RISK REDUCTION;
ANTAGONISTS AND INHIBITORS;
BLOOD;
CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
CHOLESTEROL ESTER TRANSFER PROTEINS;
CHOLESTEROL, HDL;
HUMANS;
|
|
EID: 84953738712
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0116-5 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
